MMP-9

By Type:	Pan (45) Selective (11)
By Effects:	Inhibitors (50) Agonist (1) Activators (2)

Cat. No.	Product Name	Effect	Purity

HY-15768

Ilomastat	Inhibitor	98.33%
Ilomastat (GM6001) is a potent and broad spectrum matrix metalloprotease (MMP) inhibitor, inhibits MMPs (IC₅₀s, 1.5 nM for MMP-1; 1.1 nM for MMP-2; 1.9 nM for MMP-3; 0.5 nM for MMP-9), with a K_i of 0.4 nM for human skin fibroblast collagenase (MMP-1).

HY-N0431

Astragaloside IV	Inhibitor	≥98.0%
Astragaloside IV, an active component isolated from Astragalus membranaceus, suppresses the activation of ERK1/2 and JNK, and downregulates matrix metalloproteases (MMP)-2, (MMP)-9 in MDA-MB-231 breast cancer cells.

HY-12354

SB-3CT	Inhibitor	99.35%
SB-3CT is a potent and competitive matrix metalloproteinase MMP-2 and MMP-9 inhibitor with K_i values of 13.9 and 600 nM, respectively.

HY-N0318

Salvianolic acid A		99.72%
Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation.

HY-135232

MMP-9-IN-1	Inhibitor	99.71%
MMP-9-IN-1 is a specific matrix metalloproteinase-9 (MMP-9) inhibitor, which selectively target the hemopexin (PEX) domain of MMP-9, but not other MMPs.

HY-114785

BPHA	Inhibitor
BPHA is a potent and orally active MMP-2, MMP-9 and MMP-14 inhibitor with IC₅₀s of 12 nM, 16 nM and 17 nM, respectively.

HY-131417

cis-ACCP	Inhibitor
cis-ACCP is an orally active antimetastatic matrix metalloproteinase-2 (MMP-2) selective inhibitor.

HY-P3513

β-Neo-Endorphin	Activator
β-Neo-Endorphin is an endogenous opioid peptide.

HY-N1463

Luteolin 7-O-glucuronide	Inhibitor	99.80%
Luteolin 7-O-glucuronide could inhibit Matrix Metalloproteinases (MMP) activities, with IC₅₀s of 17.63, 7.99, 11.42, 12.85, 0.03 μM for MMP-1, MMP-3, MMP-8, MMP-9, MMP-13, respectively.

HY-103444

ARP-100	Inhibitor	≥99.0%
ARP-100 is a potent and selective matrix metalloproteinase MMP-2 inhibitor (IC₅₀=12 nM).

HY-P2036A

FSL-1 TFA	Agonist	99.30%
FSL-1 TFA, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection.

HY-12170A

Prinomastat hydrochloride	Inhibitor	≥98.0%
Prinomastat hydrochloride (AG3340 hydrochloride) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC₅₀s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively.

HY-107394

UK 356618	Inhibitor	98.91%
UK 356618 (Compound 4j) is a potent and selective inhibitor of matrix metalloprotease-3 (MMP-3) with an IC₅₀ of 5.9 nM.

HY-N1454

Apigenin-7-glucuronide	Inhibitor	98.83%
Apigenin-7-glucuronide could inhibit Matrix Metalloproteinases (MMP) activities, with IC₅₀s of 12.87, 22.39, 17.52, 0.27 μM for MMP-3, MMP-8, MMP-9, MMP-13, respectively.

HY-N0532

Morroniside	Inhibitor	98.55%
Morroniside has neuroprotective effect by inhibiting neuron apoptosis and MMP2/9 expression.

HY-106992

S 3304	Inhibitor	99.11%
S 3304 is a novel matrix metalloproteinases (MMP) inhibitor specific for MMP-2 and MMP-9.

HY-114091

PF-00356231 hydrochloride	Inhibitor	99.52%
PF-00356231 hydrochloride is a specific, non-peptidic, non-zinc chelating ligand and inhibitor of matrix metalloproteinase MMP-12 (IC₅₀=1.4 μM).

HY-12170

Prinomastat	Inhibitor	≥98.0%
Prinomastat (AG3340) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC₅₀s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively.

HY-N0785

Ginkgolide C	Activator	≥98.0%
Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease.

HY-107428

PD-166793	Inhibitor	≥99.0%
PD-166793 is a potent, selective, orally active and wide‐broad spectrum inhibitor of MMP, exhibiting nanomolar potency against MMP-2, MMP-3 and MMP-13 (IC₅₀=4, 7, and 8 nM, respectively) and micromolar potency vs MMP-1, -7 and -9 (IC₅₀=6.0, 7.2, and 7.9 μM, respectively).

Name
Email *

	Sorry, but the email address you supplied was invalid.

MMP-9 Related Products (57)